Clinical trial · Interventional
Virtual Reality for Improving Symptoms in Palliative Care
NCT05197894CI-TRIAL-00076847VRPCunknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The objective of this study is to determine whether VR can ameliorate symptoms for palliative care patients within a hospice setting. We also aim to verify the efficacy with a larger sample size than previously shown, as well as extend the population to include non-cancer patients receiving Hospice care. We will further attempt to delineate whether there is a sustainability of symptomatic improvement one week after VR experiences.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer and Non-cancer Hospice Patients | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Virtual Reality | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- VR experience
- description
- Participants will be given a list of VR applications to choose from. They will then be given instructions by a research assistant (approximately 10 minutes) on how to use the selected application they have chosen, as well as time for any questions they may have before starting their VR experience. They will then have an approximately 30-minute session of that VR experience. They may or may not be accompanied by a family member or significant other and will also have a research assistant available to aid them in any difficulties experienced during the VR experience.
- interventionNames
- Device: Virtual Reality
Primary outcomes (1)
- measure
- VR experience effect on pain, shortness of breath, depression, anxiety, and well-being scores (0 - 10)
- timeFrame
- ESAS scores measured immediately before VR experience will be compared to ESAS scores measured immediately after VR experience
- description
- The primary outcome of this study will be a significant difference in change of ESAS score for 5 key symptoms (pain, shortness of breath, depression, anxiety, and well-being) immediately before and after a VR experience.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * at least 18 years or older * admitted to Hospice for Specialty Palliative Care Exclusion Criteria: * Palliative Performance Scale (PPS) ≤ 20% * severe cognitive impairment leading to inability to provide ESAS scores for 5 key symptoms measured in this study * severe visual and/or hearing impairment preventing use of VR (glasses and hearing aids may be worn during VR sessions and do not exclude participation) * absolute inability to sit * paralysis of an upper limb * participant dies before VR experience
References
Publications (0)
Data not yet available
No reference posted for this study.